Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen H Gillespie

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
The Lancet. Infectious Diseases|September 27, 2005
Antibiotic resistance markers in genetically modified plants: a risk to human health?Philippe B Gay, Stephen H Gillespie
The New England Journal of Medicine|February 5, 2015
Shorter moxifloxacin-based regimens for drug-sensitive tuberculosisStephen H Gillespie, Carl M Mendel,
Journal of Medical Microbiology|June 8, 2001
A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum modelStephen H Gillespie, Ian Morrissey, Dean Everett
Journal of Medical Microbiology|June 4, 2020
Improving the recovery and detection of bloodstream pathogens from blood cultureKerry Falconer, Robert Hammond, Stephen H Gillespie
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2017
Mycobacterial Load AssayStephen H Gillespie, Wilber Sabiiti, Katarina Oravcova
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2024
Rapid Drug Susceptibility Testing to Preserve AntibioticsStephen H Gillespie, Robert J H Hammond
Ebiomedicine|November 12, 2020
Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteriaJan Heyckendorf, Stephen H Gillespie, Morten Ruhwald
Journal of Medical Microbiology|July 18, 2003
Severe acute respiratory syndrome (SARS): breath-taking progressPeter M Hawkey, Sanjay Bhagani, Stephen H Gillespie
The New England Journal of Medicine|June 2, 2016
Therapy for Tuberculous MeningitisMartin J Boeree, Stephen H Gillespie, Michael Hoelscher, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 18, 2002
Evolutionary barriers to quinolone resistance in Streptococcus pneumoniaeStephen H Gillespie, Leroy L Voelker, Anne Dickens
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
The Lancet. Infectious Diseases|September 27, 2005
Antibiotic resistance markers in genetically modified plants: a risk to human health?Philippe B Gay, Stephen H Gillespie
The New England Journal of Medicine|February 5, 2015
Shorter moxifloxacin-based regimens for drug-sensitive tuberculosisStephen H Gillespie, Carl M Mendel,
Journal of Medical Microbiology|June 8, 2001
A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum modelStephen H Gillespie, Ian Morrissey, Dean Everett
Journal of Medical Microbiology|June 4, 2020
Improving the recovery and detection of bloodstream pathogens from blood cultureKerry Falconer, Robert Hammond, Stephen H Gillespie
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2017
Mycobacterial Load AssayStephen H Gillespie, Wilber Sabiiti, Katarina Oravcova
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2024
Rapid Drug Susceptibility Testing to Preserve AntibioticsStephen H Gillespie, Robert J H Hammond
Ebiomedicine|November 12, 2020
Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteriaJan Heyckendorf, Stephen H Gillespie, Morten Ruhwald
Journal of Medical Microbiology|July 18, 2003
Severe acute respiratory syndrome (SARS): breath-taking progressPeter M Hawkey, Sanjay Bhagani, Stephen H Gillespie
The New England Journal of Medicine|June 2, 2016
Therapy for Tuberculous MeningitisMartin J Boeree, Stephen H Gillespie, Michael Hoelscher, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 18, 2002
Evolutionary barriers to quinolone resistance in Streptococcus pneumoniaeStephen H Gillespie, Leroy L Voelker, Anne Dickens
Pageof 16